Benjamin L. Palleiko

2017

In 2017, Benjamin L. Palleiko earned a total compensation of $923.9K as Chief Business Officer and Chief Financial Officer at Carbylan Therapeutics.

Compensation breakdown

Bonus$95,000
Option Awards$589,390
Salary$239,492
Total$923,882

Palleiko received $589.4K in option awards, accounting for 64% of the total pay in 2017.

Palleiko also received $95K in bonus and $239.5K in salary.

Rankings

In 2017, Benjamin L. Palleiko's compensation ranked 9,338th out of 14,666 executives tracked by ExecPay. In other words, Palleiko earned more than 36.3% of executives.

ClassificationRankingPercentile
All
9,338
out of 14,666
36th
Division
Manufacturing
3,587
out of 5,772
38th
Major group
Chemicals And Allied Products
1,235
out of 2,075
41st
Industry group
Drugs
994
out of 1,731
43rd
Industry
Pharmaceutical Preparations
781
out of 1,333
41st
Source: SEC filing on August 23, 2019.

Palleiko's colleagues

We found one more compensation record of an executive who worked with Benjamin L. Palleiko at Carbylan Therapeutics in 2017.

2017

T Crockett

Carbylan Therapeutics

Chief Executive Officer

News

In-depth

You may also like